Alliancebernstein L.P. Purchases 31,064 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Alliancebernstein L.P. grew its position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 21.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 179,152 shares of the company's stock after purchasing an additional 31,064 shares during the period. Alliancebernstein L.P. owned approximately 0.14% of Henry Schein worth $12,397,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Norges Bank acquired a new stake in Henry Schein in the 4th quarter valued at approximately $103,301,000. Raymond James Financial Inc. bought a new position in shares of Henry Schein in the fourth quarter worth $34,720,000. ING Groep NV increased its holdings in shares of Henry Schein by 34.1% during the fourth quarter. ING Groep NV now owns 1,163,087 shares of the company's stock valued at $80,486,000 after purchasing an additional 295,785 shares during the period. Wolverine Asset Management LLC acquired a new stake in Henry Schein in the fourth quarter worth about $12,179,000. Finally, Amundi grew its position in Henry Schein by 12.0% in the 4th quarter. Amundi now owns 736,637 shares of the company's stock valued at $52,345,000 after buying an additional 79,056 shares in the last quarter. Institutional investors and hedge funds own 96.62% of the company's stock.

Henry Schein Stock Down 1.9 %

Shares of HSIC traded down $1.26 during trading hours on Tuesday, hitting $64.35. 290,069 shares of the company were exchanged, compared to its average volume of 1,601,501. The company has a market cap of $7.99 billion, a PE ratio of 26.49, a PEG ratio of 2.13 and a beta of 0.84. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The firm's 50 day moving average is $71.58 and its 200-day moving average is $72.19. Henry Schein, Inc. has a 52 week low of $60.56 and a 52 week high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing analysts' consensus estimates of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. During the same quarter in the previous year, the firm posted $0.66 earnings per share. Henry Schein's quarterly revenue was up 5.8% compared to the same quarter last year. On average, equities research analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Wall Street Analyst Weigh In

HSIC has been the topic of a number of recent analyst reports. Wells Fargo & Company started coverage on shares of Henry Schein in a research report on Friday, February 14th. They set an "equal weight" rating and a $80.00 price target on the stock. UBS Group cut their target price on Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a research report on Wednesday, February 26th. Barrington Research reiterated an "outperform" rating and set a $90.00 price target on shares of Henry Schein in a research report on Wednesday, February 26th. StockNews.com upgraded Henry Schein from a "hold" rating to a "buy" rating in a report on Wednesday, April 9th. Finally, Bank of America raised Henry Schein from an "underperform" rating to a "buy" rating and raised their target price for the company from $69.00 to $84.00 in a research note on Monday, January 6th. Five research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $81.10.

Insider Activity at Henry Schein

In other news, CEO Bradford C. Connett sold 4,036 shares of the business's stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the sale, the chief executive officer now directly owns 62,688 shares in the company, valued at approximately $4,460,251.20. The trade was a 6.05 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Philip A. Laskawy sold 2,604 shares of the firm's stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the transaction, the director now directly owns 24,805 shares of the company's stock, valued at $1,762,147.20. The trade was a 9.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is owned by corporate insiders.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.